<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01115595</url>
  </required_header>
  <id_info>
    <org_study_id>336/2552</org_study_id>
    <nct_id>NCT01115595</nct_id>
  </id_info>
  <brief_title>Efficacy of Allergen Immunotherapy for Allergic Rhinitis in Thais</brief_title>
  <official_title>Efficacy of Mite Allergen Vaccine Among Thai Patients With Allergic Rhinitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mahidol University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Research Council of Thailand</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Mahidol University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to study the efficacy of allergen injection immunotherapy for
      allergic rhinitis by

        -  symptoms score

        -  medication score

        -  quality of life

        -  immunologic test from blood
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Compare the efficacy of allergen injection immunotherapy between the treatment group and the
      placebo group after injection for

        -  2 months

        -  6 months

        -  12 months
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>March 2010</start_date>
  <completion_date type="Anticipated">March 2013</completion_date>
  <primary_completion_date type="Anticipated">March 2013</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Total nasal symptoms score</measure>
    <time_frame>average within 1 week</time_frame>
    <description>3 point scale (0,1,2,3) and combination of
nasal block
rhinorrhea
itching
sneezing</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Combined total symptoms score and medication score</measure>
    <time_frame>average within 1 week</time_frame>
    <description>Total symptom score (nasal block, rhinorrhea, itching, sneezing, and eye symptoms with chest symptoms = Maximal score --&gt; 18 devided by 6 = 3) PLUS medication score ( antihistamine = 1, topical nasal steroid = 2; --&gt; Maximal score = 3).</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Rhinitis, Allergic, Perennial</condition>
  <arm_group>
    <arm_group_label>Placebo injection</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Placebo injection with standard medication (oral antihistamine and/or topical nasal steroid)</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Mite allergen extract</intervention_name>
    <description>Dermatophagoides pteronyssinus from ALK company</description>
    <arm_group_label>Placebo injection</arm_group_label>
    <other_name>Allegen extract (D.p) from ALK company. 10,000 AU/ml</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients with the symptoms of allergic rhinitis who sensitized to mite
             (Dermatophagoides pteronyssinus)

          -  positive skin prick test to D.p. at 4+ degree

        Exclusion Criteria:

          -  steroid dependent asthma

          -  force expiratory volume (FEV1) less than 70% of predicted value

          -  previous injection immunotherapy within 2 years

          -  pregnancy

          -  medical conditions such as ischemic heart disease, autoimmune disease, cancer,
             previous history of anaphylaxis
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pongsakorn Tantilipikorn, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Division of allergy and rhinology, Faculty of Medicine Siriraj, Mahidol University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Pongsakorn Tantilipikorn, M.D.</last_name>
    <phone>+66 2 419 7409</phone>
    <email>siptv@mahidol.ac.th</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Bangon Pinkaew, M.Sc.</last_name>
    <phone>+66 2 4197409</phone>
    <email>sispi@mahidol.ac.th</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Division of Allergy and Rhinology, Faculty of Medicine Siriraj, Mahidol University</name>
      <address>
        <city>Bangkok</city>
        <zip>10700</zip>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bangon Pinkaew, M.Sc.</last_name>
      <phone>+66 2 419 7409</phone>
      <email>sispi@mahidol.ac.th</email>
    </contact>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <verification_date>August 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 1, 2010</study_first_submitted>
  <study_first_submitted_qc>May 3, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 4, 2010</study_first_posted>
  <last_update_submitted>August 2, 2011</last_update_submitted>
  <last_update_submitted_qc>August 2, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 3, 2011</last_update_posted>
  <responsible_party>
    <name_title>National Research Council of Thailand</name_title>
    <organization>National Research Council of Thailand</organization>
  </responsible_party>
  <keyword>Allergic rhinitis</keyword>
  <keyword>Allergen injection immunotherapy</keyword>
  <keyword>Efficacy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rhinitis</mesh_term>
    <mesh_term>Rhinitis, Allergic</mesh_term>
    <mesh_term>Rhinitis, Allergic, Perennial</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

